Polypharmacy and major adverse events in atrial fibrillation.
J Cardiovasc Pharmacol. 2022 Jul 29. doi: 10.1097/FJC.0000000000001339. Online ahead of print.
J Cardiovasc Pharmacol. 2022.
PMID: 35921643